Meeting
2018 ASCO Annual Meeting
Risk of chronic comorbidities in survivors of adolescent and young adult cancer (AYA).
Authors
Chun Chao
Kaiser Permanente Southern California, Pasadena, CA
Chun Chao , Lanfang Xu , Kimberly L. Cannavale , F. Lennie Wong , Po-Yin S Huang , Robert Michael Cooper , Smita Bhatia , Saro Armenian
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Patient and Survivor Care
Track
Patient and Survivor Care
Sub Track
Late and Long-Term Effects
Citation
J Clin Oncol 36, 2018 (suppl; abstr 10015)
DOI
10.1200/JCO.2018.36.15_suppl.10015
Abstract #
10015
Poster Bd #
3
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Risk-adapted therapy utilizing upfront brentuximab vedotin (Bv) and rituximab (R) with reduced toxicity chemotherapy in children, adolescents, and young adults with Hodgkin lymphoma.
First Author: Jessica Hochberg
Poster
2016 Cancer Survivorship Symposium
Community survivorship program: Kansas Hope in the Valley program.
First Author: Cynthia Chauhan
Poster
2016 Cancer Survivorship Symposium
Cumulative burden of morbidity (CBM) among testicular cancer survivors (TCS) in the Platinum study.
First Author: Sarah L Kerns
Poster
2012 Gastrointestinal Cancers Symposium
Patient-reported toxicities and comorbidities after treatment for cancers of the upper gastrointestinal tract.
First Author: James M. Metz